{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:05:11Z","timestamp":1790006711809,"version":"4.0.1"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:p>This cross-sectional study investigates the association of descheduling of gabapentin with use among Medicaid enrollees in Michigan.<\/jats:p>","DOI":"10.1001\/jamanetworkopen.2026.35059","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:30:48Z","timestamp":1790004648000},"page":"e2635059","source":"Crossref","is-referenced-by-count":0,"title":["Gabapentin Use in Medicaid After Descheduling"],"prefix":"10.1001","volume":"9","author":[{"given":"Katherine","family":"Gora Combs","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill"},{"name":"UNC Injury Prevention Research Center, University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihsuan","family":"Lo-Ciganic","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, School of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"},{"name":"North Florida\/South Georgia Veterans Health System, Geriatric Research Education and Clinical Center, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingye","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Hincapie-Castillo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"zld260209r1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2026.113026","article-title":"Gabapentin utilization and nontherapeutic use relative to select comparator drugs, United States 2013-2022.","volume":"279","author":"Karami","year":"2026","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"zld260209r2","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/archinte.166.9.1021","article-title":"Off-label prescribing among office-based physicians.","volume":"166","author":"Radley","year":"2006","journal-title":"Arch Intern Med"},{"issue":"1","key":"zld260209r3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40265-020-01432-7","article-title":"Abuse and misuse of pregabalin and gabapentin: a systematic review update.","volume":"81","author":"Evoy","year":"2021","journal-title":"Drugs"},{"key":"zld260209r5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2025.105064","article-title":"A comprehensive analysis of jurisdiction-specific laws related to scheduling or required prescription drug monitoring of gabapentin in the United States, 2016-2024.","volume":"147","author":"Gora Combs","year":"2026","journal-title":"Int J Drug Policy"},{"key":"zld260209r7","doi-asserted-by":"publisher","DOI":"10.1177\/29767342261456625","article-title":"Decreased gabapentin prescription fills among Medicaid enrollees following state-level schedule V controlled substance classification in Kentucky and West Virginia.","author":"Gora Combs","year":"2026","journal-title":"Subst Use Addctn J"},{"issue":"19","key":"zld260209r10","doi-asserted-by":"publisher","first-page":"664","DOI":"10.15585\/mmwr.mm7119a3","article-title":"Notes from the field: trends in gabapentin detection and involvement in drug overdose deaths\u201423 states and the District of Columbia, 2019-2020.","volume":"71","author":"Mattson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zld260209r4","unstructured":"Food and Drug Administration. Neurontin, Gralise, Horizant (gabapentin) and Lyrica, Lyrica CR (pregabalin): drug safety communication\u2014serious breathing problems. Posted December 19, 2019. Accessed August 14, 2026. https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/neurontin-gralise-horizant-gabapentin-and-lyrica-lyrica-cr-pregabalin-drug-safety-communication"},{"key":"zld260209r6","unstructured":"Shaltry? J. Regulatory impact statement and cost-benefit analysis\u20142022-6 LR. Michigan Office of Administrative Hearings and Rules: Administrative Rules Division. August 15, 2023. Accessed June 12, 2025. https:\/\/ars.apps.lara.state.mi.us\/Transaction\/DownloadFile?FileName=RISForm_2022-6_LR.pdf&FileType=RISForm&TransactionID=1365&EffectiveDate=5%2F28%2F2024&ReturnHTML=True"},{"key":"zld260209r8","unstructured":"Medicaid. State drug utilization data. Accessed May 7, 2026. https:\/\/www.medicaid.gov\/medicaid\/prescription-drugs\/state-drug-utilization-data\/index.html"},{"key":"zld260209r9","unstructured":"Centers for Medicare & Medicaid Services. Medicaid and CHIP enrollment data. Accessed May 7, 2026. https:\/\/www.medicaid.gov\/medicaid\/national-medicaid-chip-program-information\/medicaid-chip-enrollment-data"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2854273\/gora_combs_2026_ld_260209_1789154687.96952.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:30:49Z","timestamp":1790004649000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2854273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.35059","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}